NR4A1 and breast cancer: BC is a disease with complex etiology and high heterogeneity, can be divided into three types, hormone receptor positive (estrogen and progesterone), human epidermal growth factor receptor 2 (HER2) positive and triple negative breast cancer (TNBC, accounting for 10%–20% of BC cases) (Karami Fath et al., 2022).